When to seek care, even after checking glucose
Sudden deterioration, a curtain, many new dots or a dark area appearing abruptly needs immediate assessment. Call 112 for major visual loss or sudden blackout, even if vision returns, or for associated neurological symptoms. Do not drive. An unusual glucose reading does not exclude a retinal or circulation problem.
If vision has been less clear for days, keeps changing or affects one eye more, contact your treating team and arrange ophthalmic assessment. A new fixed patch or wavy lines merits prompt contact. For symptoms or readings covered by your diabetes emergency plan, follow the agreed instructions and also report the visual change.
How glucose can temporarily change focus
Large changes in glucose can temporarily alter focusing. Your usual or newly prescribed glasses may seem unsuitable for a period. This can occur during changes in glucose or treatment. The current reading and recent pattern are useful clues, not proof of the cause.
If examination excludes other problems and glucose is still stabilising, the clinician may recommend repeating refraction before buying a definitive new prescription. Do not change diabetes medicines or insulin yourself because vision is blurred. Bring medication details, recent changes and readings already recorded. Diabetes treatment decisions belong with the team managing it.
Retinopathy and macular oedema
Diabetes can damage small retinal vessels. In early stages, vision may remain good without noticeable symptoms. Fluid accumulating in the macula, the central area responsible for detail, can make reading, recognising faces or seeing clear lines difficult. This is diabetic macular oedema. Its location helps determine the effect on vision.
In advanced disease, abnormal vessels can grow and bleed into the vitreous, producing haze, dots or abrupt visual deterioration. Advanced retinopathy is not the only explanation for blur in diabetes: cataract, the ocular surface and other diseases also need consideration. Describe whether the whole image blurs, the centre is missing or new floaters appear.

When retinal checks are scheduled
The 2026 American Diabetes Association recommendations call for an initial eye examination at diagnosis for adults with type 2 diabetes, and generally within five years of onset for type 1 diabetes. Later intervals depend on findings, metabolic control and circumstances. Established retinopathy may need closer review. Your team can adapt the interval to the local care pathway.
If you have pre-existing diabetes and are planning pregnancy or are pregnant, discuss eye care early. Checks may be needed before or early in pregnancy and subsequently according to findings. Isolated gestational diabetes follows different recommendations. These intervals concern planned surveillance; new symptoms do not wait for the next due date.
What a retinal examination and OCT show
A dilated examination assesses retinal vessels, the retina and possible bleeding. Retinal photography can be used in screening programmes, which need a referral pathway for abnormal or ungradable images. OCT provides cross-sectional images of the macula and can detect fluid or thickness changes. A normal central OCT alone does not describe every area where retinopathy may occur.
Findings guide monitoring, macular treatment or other retinal therapy. Glucose, blood pressure and other risk-factor management also matters and is coordinated with the diabetes team. Ask when the retina should be reviewed and which symptoms should bring it forward. Bring reports and ensure findings reach the clinician managing your diabetes.
Why retinal screening matters even if glasses work
Corrective lenses may provide good vision despite early retinal changes. Measuring vision for glasses and screening for diabetic retinopathy are therefore different tasks. When booking, ask whether retinal assessment is included or requires a separate appointment. A normal result should come with an appropriate next-review interval.
During treatment changes and variable glucose, describe both visual and glucose patterns. They may be related and can also coexist with retinal disease. Do not wait until buying new glasses to report persistent new haze. Abrupt deterioration or a curtain requires immediate assessment.
Injections, laser and vitrectomy have different aims
Intravitreal injections deliver medicine inside the eye. In diabetic macular oedema, anti-VEGF medicines may be used to reduce a signal involved in vessel leakage and growth. Decisions depend on vision, central involvement and eye characteristics. Repeated treatment and monitoring may be needed; one injection is not a promise of a permanent cure.
Laser indications depend on disease stage and location. In proliferative retinopathy it can reduce the drive for abnormal vessel growth. Medicines, laser or a combination may be chosen, with the ability to attend subsequent appointments also relevant.
Vitrectomy is surgery that may help certain persistent vitreous haemorrhages or retinal traction. Not every new floater in a person with diabetes requires it. Ask which problem treatment targets and how success will be measured. Improving clarity and reducing future visual-loss risk are related but distinct aims.
Better glucose control does not end retinal follow-up
Managing glucose, blood pressure and other risk factors helps protect vision. A good reading today does not automatically erase existing retinal changes. Keep retinal appointments even when you feel well and your glasses work.
If diabetes treatment is intensified, tell the team about known retinopathy and your latest eye examination. In some people, a large rapid glucose reduction can be associated with initial worsening of retinopathy. This is a reason to coordinate treatment and retinal surveillance, not to abandon better metabolic control.
Do not compare your review interval directly with another person’s. No retinopathy, treated macular oedema and proliferative disease have different needs. If you miss an appointment, ask how soon it should be rescheduled according to your findings rather than automatically waiting another year. New symptoms should be reported regardless of the next planned date.
Sources · National Eye Institute · Diabetic retinopathy · ADA · Standards of Care in Diabetes, 2026 · Retinopathy
All sources and further reading (8)
- Ministero della Salute – Ictus e TIA
- National Eye Institute – Retinal detachment
- NIDDK · Diabetic eye disease
- National Eye Institute · Eyeglasses for refractive errors
- American Society of Retina Specialists – Macular edema
- American Society of Retina Specialists – Vitrectomy
Illustrative images from the website’s image library.
- AI-generated illustrative image
- AI-generated illustrative image
